Evidence mapPaperPMID 28631302Full record

ArticleBritish journal of pharmacology2018

l-Homocysteine-induced cathepsin V mediates the vascular endothelial inflammation in hyperhomocysteinaemia.

Yi-Ping Leng, Ye-Shuo Ma, Xiao-Gang Li, Rui-Fang Chen, Ping-Yu Zeng, Xiao-Hui Li, Cheng-Feng Qiu, Ya-Pei Li, Zhen Zhang, Alex F Chen

Open access · bronzeAbstract read
In one paragraph

Article in British journal of pharmacology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it, 37 citations in OpenAlex.

  1. Pooled it
  2. Observational
  3. Article
  4. Article
  5. Folate and Vitamin BNutrients · 2023
    Article
  6. Small Vessel Disease: Ancient Description, Novel Biomarkers.International journal of molecular sciences · 2022
    Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Yi-Ping LengXiangya School of Pharmaceutical Sciences, Central South University, Changsha, China.
Ye-Shuo MaCenter for Vascular Disease and Translational Medicine, The Third Xiangya Hospital of Central South University, Changsha, China.
Xiao-Gang LiCenter for Vascular Disease and Translational Medicine, The Third Xiangya Hospital of Central South University, Changsha, China.
Rui-Fang ChenCenter for Vascular Disease and Translational Medicine, The Third Xiangya Hospital of Central South University, Changsha, China.
Ping-Yu ZengCenter for Vascular Disease and Translational Medicine, The Third Xiangya Hospital of Central South University, Changsha, China.
Xiao-Hui LiXiangya School of Pharmaceutical Sciences, Central South University, Changsha, China.
Cheng-Feng QiuXiangya School of Pharmaceutical Sciences, Central South University, Changsha, China.
Ya-Pei LiCenter for Vascular Disease and Translational Medicine, The Third Xiangya Hospital of Central South University, Changsha, China.
Zhen ZhangCenter for Vascular Disease and Translational Medicine, The Third Xiangya Hospital of Central South University, Changsha, China.
Alex F ChenXiangya School of Pharmaceutical Sciences, Central South University, Changsha, China.ORCID 0000-0002-9792-0916
Central South University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background and purposeVascular inflammation, including the expression of inflammatory cytokines in endothelial cells, plays a critical role in hyperhomocysteinaemia-associated vascular diseases. Cathepsin V, specifically expressed in humans, is involved in vascular diseases through its elastolytic and collagenolytic activities. The aim of this study was to determine the effects of cathepsin V on l-homocysteine-induced vascular inflammation. EXPERIMENTAL APPROACH: A high methionine diet-induced hyperhomocysteinaemic mouse model was used to assess cathepsin V expression and vascular inflammation. Cultures of HUVECs were challenged with l-homocysteine and the cathepsin L/V inhibitor SID to assess the pro-inflammatory effects of cathepsin V. Transfection and antisense techniques were utilized to investigate the effects of cathepsin V on the dual-specificity protein phosphatases (DUSPs) and MAPK pathways. KEY

resultsCathepsin L (human cathepsin V homologous) was increased in the thoracic aorta endothelial cells of hyperhomocysteinaemic mice; l-homocysteine promoted cathepsin V expression in HUVECs. SID suppressed the activity of cathepsin V and reversed the up-regulation of inflammatory cytokines (IL-6, IL-8 and TNF-α), adhesion and chemotaxis of leukocytes and vascular inflammation induced by l-homocysteine in vivo and in vitro. Increased cathepsin V promoted the degradation of DUSP6 and DUSP7, phosphorylation and subsequent nuclear translocation of ERK1/2, phosphorylation of STAT1 and expression of IL-6, IL-8 and TNF-α. CONCLUSIONS AND IMPLICATIONS: This study has identified a novel mechanism, which shows that l-homocysteine-induced upregulation of cathepsin V mediates vascular endothelial inflammation under high homocysteine condition partly via ERK LINKED ARTICLES: This article is part of a themed section on Spotlight on Small Molecules in Cardiovascular Diseases. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v175.8/issuetoc.

Indexed as

AnimalsAorta, ThoracicCathepsinsCell AdhesionCells, CulturedEndothelium, VascularHomocysteineHumansHuman Umbilical Vein Endothelial CellsHyperhomocysteinemiaMaleMice, Inbred C57BLMitogen-Activated Protein KinasesTHP-1 CellsVascular DiseasesCathepsinsHomocysteineMitogen-Activated Protein Kinases

Identifiers

PMID28631302
PMCPMC5866977
OpenAlexW2712379096

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.